VANGUARD GROUP INC - CITIUS PHARMACEUTICALS INC ownership

CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 61 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CITIUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,672,741
-41.7%
6,827,500
+2.2%
0.00%
Q2 2023$8,017,351
+13.2%
6,681,126
+10.4%
0.00%
Q1 2023$7,083,564
+49.1%
6,054,328
+0.7%
0.00%
Q4 2022$4,751,081
-32.5%
6,014,027
+3.4%
0.00%
Q3 2022$7,036,000
+33.4%
5,814,961
+1.4%
0.00%
Q2 2022$5,276,000
-52.6%
5,735,361
-7.7%
0.00%
Q1 2022$11,128,000
+17.0%
6,216,638
+0.6%
0.00%
Q4 2021$9,512,000
-18.9%
6,176,610
+6.9%
0.00%
Q3 2021$11,730,000
-40.4%
5,778,286
+2.2%
0.00%
Q2 2021$19,672,000
+118.1%
5,652,813
+11.6%
0.00%
Q1 2021$9,018,000
+1071.2%
5,066,235
+570.9%
0.00%
Q4 2020$770,000
+29.2%
755,119
+31.8%
0.00%
Q3 2020$596,000
-2.1%
572,938
+6.2%
0.00%
Q2 2020$609,000
+118.3%
539,349
+16.1%
0.00%
Q1 2020$279,000
-41.5%
464,406
-0.6%
0.00%
Q4 2019$477,000
+32.5%
467,2280.0%0.00%
Q3 2019$360,000
-18.9%
467,228
+3.1%
0.00%
Q2 2019$444,000
+181.0%
453,156
+308.3%
0.00%
Q1 2019$158,000
+182.1%
110,976
+105.6%
0.00%
Q4 2018$56,000
-37.8%
53,965
+2.6%
0.00%
Q3 2018$90,000
-20.4%
52,615
+7.1%
0.00%
Q2 2018$113,000
+39.5%
49,115
+88.5%
0.00%
Q1 2018$81,000
+88.4%
26,052
+135.8%
0.00%
Q4 2017$43,00011,0500.00%
Other shareholders
CITIUS PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Inspire Advisors, LLC 196,867$181,0000.05%
Wealth Advisory Solutions, LLC 156,850$144,0000.04%
Horst & Graben Wealth Management LLC 75,722$70,0000.02%
Ergoteles LLC 451,890$416,0000.01%
Miller Investment Management, LP 50,000$46,0000.01%
Virtu Financial LLC 81,410$75,0000.01%
Y-Intercept (Hong Kong) Ltd 17,342$16,0000.00%
Kestra Advisory Services, LLC 71,102$65,0000.00%
Csenge Advisory Group 15,000$14,0000.00%
Qube Research & Technologies Ltd 121,281$112,0000.00%
View complete list of CITIUS PHARMACEUTICALS INC shareholders